Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
Scott A. Halperin(Dalhousie University), Lingyun Ye(Nova Scotia Health Authority), Donna MacKinnon‐Cameron(Nova Scotia Health Authority), Bruce R. Smith(Dalhousie University), Pedro Cahn(Fundación Huésped), Guillermo M. Ruiz‐Palacios(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Aamer Ikram(National Institute of Health), Fernando Laņas(Universidad de La Frontera), M. Lourdes Guerrero(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Sergio Raúl Muñoz Navarro(Universidad de La Frontera), Omar Sued(Fundación Huésped), Dmitry Lioznov(Research Institute of Influenza), Vitalina Dzutseva(Novosibirsk State University), Ghazala Parveen(National Institute of Health), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Laura Leppan(Nova Scotia Health Authority), Joanne M. Langley(Dalhousie University), Luis Barreto(CanSino (China)), Jin-Bo Gou(CanSino (China)), Tao Zhu(CanSino (China)), Helen Mao, Luc Gagnon, Steven-Phay Tran, S. Khan, Amalia Guadalupe Becerra Aquino, Edgar Eduardo Saldaña Montemayor, Norma E. Rivera-Martínez, Víctor Casildo Bohórquez López, Jesus Abraham Simón Campos, Felipe de Jesús Pineda Cárdenas, Wei Chen, Lihua Hou, Zhe Zhang, Gonzalo Corral, Eduardo López, Ricardo Teijeiro, María Fernanda Alzogaray, Cesar Javier Zaidman, Gustavo Lopardo, Bernardo Goecke, Rosa María Feijooó Seoane, Sayed Faisal Mahmood, Ejaz Ahmed Khan, Jayed Akram, Salma Abbas, Naseem Salahuddin, E. G. Rozhkova, Tatyana Zubkova
Cited by 237Open Access
Abstract
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al.|New England Journal of Medicine|2020|15.5k
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink et al.|New England Journal of Medicine|2020|10.7k
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
L.R. Baden|Bulletin of Miscellaneous Information (Royal Gardens Kew)|2020|7.3k